Journal of Neurosurgery Spine · 2014 · 71 citations · 73 references
EngineeringOrthopaedic SurgerySurgeryCell TherapyRegenerative MedicineTissue EngineeringBiomaterials For RegenerationCell-scaffold InteractionsMesenchymal Stem Cell TherapyRegenerative ScaffoldsTissue Engineering ScaffoldsTissue Engineering With Stem CellsAnimal Disease ModelsChronic Low Back PainFibrin BiomaterialsMesenchymal RegenerationProgenitor CellsRecurrent Prolapse RepairScaffold-based RegenerationTissue Regeneration Scaffolds
OBJECT: Following microdiscectomy, discs generally fail to undergo spontaneous regeneration and patients may experience chronic low-back pain and recurrent disc prolapse. In published studies, formulations of mesenchymal progenitor cells combined with pentosan polysulfate (MPCs+PPS) have been shown to regenerate disc tissue in animal models, suggesting that this approach may provide a useful adjunct to microdiscectomy. The goal of this preclinical laboratory study was to determine if the transplantation of MPCs+PPS, embedded in a gelatin/fibrin scaffold (SCAF), and transplanted into a defect created by microdiscectomy, could promote disc regeneration. METHODS: A standardized microdiscectomy procedure was performed in 18 ovine lumbar discs. The subsequent disc defects were randomized to receive either no treatment (NIL), SCAF only, or the MPC+PPS formulation added to SCAF (MPCs+PPS+SCAF). Necropsies were undertaken 6 months postoperatively and the spines analyzed radiologically (radiography and MRI), biochemically, and histologically. RESULTS: No adverse events occurred throughout the duration of the study. The MPC+PPS+SCAF group had significantly less reduction in disc height compared with SCAF-only and NIL groups (p < 0.05 and p < 0.01, respectively). Magnetic resonance imaging Pfirrmann scores in the MPC+PPS+SCAF group were significantly lower than those in the SCAF group (p = 0.0213). The chaotropic solvent extractability of proteoglycans from the nucleus pulposus of MPC+PPS+SCAF-treated discs was significantly higher than that from the SCAF-only discs (p = 0.0312), and using gel exclusion chromatography, extracts from MPC+PPS+SCAF-treated discs also contained a higher percentage of proteoglycan aggregates than the extracts from both other groups. Analysis of the histological sections showed that 66% (p > 0.05) of the MPC+PPS+SCAF-treated discs exhibited less degeneration than the NIL or SCAF discs. CONCLUSIONS: These findings demonstrate the capacity of MPCs in combination with PPS, when embedded in a gelatin sponge and sealed with fibrin glue in a microdiscectomy defect, to restore disc height, disc morphology, and nucleus pulposus proteoglycan content.
73
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Patricia A. Zuk, Min Zhu, Peter Ashjian et al. · Molecular Biology of the Cell · 2002 · 6.7K citations
Magnetic Resonance Classification of Lumbar Intervertebral Disc Degeneration
Christian W. A. Pfirrmann, Alexander Metzdorf, Marco Zanetti et al. · Spine · 2001 · 4K citations